Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.580
-0.020 (-1.25%)
Mar 9, 2026, 1:34 PM EDT - Market open
Innate Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 151 | 166 | 233 | 282 | 400 | 334 | |
| Market Cap Growth | -23.07% | -29.08% | -17.19% | -29.50% | 19.60% | -36.34% | |
| Enterprise Value | 113 | 107 | 180 | 196 | 283 | 177 | |
| Last Close Price | 1.60 | 1.84 | 2.80 | 3.73 | 4.56 | 4.09 | |
| PS Ratio | 10.18 | 7.95 | 3.43 | 4.58 | 14.24 | 3.92 | |
| PB Ratio | 25.01 | 18.11 | 4.07 | 4.87 | 3.27 | 1.75 | |
| P/TBV Ratio | 25.01 | 18.11 | 4.10 | 5.02 | 5.56 | 2.49 | |
| EV/Sales Ratio | 7.60 | 5.15 | 2.65 | 3.19 | 10.07 | 2.07 | |
| EV/EBITDA Ratio | - | - | - | - | - | 10.86 | |
| EV/EBIT Ratio | - | - | - | - | - | 133.87 | |
| Debt / Equity Ratio | 5.25 | 3.51 | 0.77 | 0.78 | 0.41 | 0.12 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 1.33 | |
| Net Debt / Equity Ratio | -6.41 | -5.63 | -1.01 | -1.09 | -0.70 | -0.85 | |
| Net Debt / EBITDA Ratio | 0.66 | 0.99 | 6.16 | 4.93 | 1.75 | -9.96 | |
| Net Debt / FCF Ratio | 0.80 | 6.83 | 1.60 | 3.01 | 1.27 | 2.52 | |
| Asset Turnover | 0.10 | 0.14 | 0.33 | 0.25 | 0.09 | 0.20 | |
| Quick Ratio | 2.08 | 2.50 | 3.51 | 3.21 | 1.67 | 3.64 | |
| Current Ratio | 2.21 | 2.60 | 3.73 | 3.38 | 1.73 | 3.81 | |
| Return on Equity (ROE) | -271.37% | -162.91% | -14.28% | -71.75% | -34.53% | -0.44% | |
| Return on Assets (ROA) | -25.92% | -22.52% | -4.23% | -4.40% | -10.40% | 0.19% | |
| Return on Invested Capital (ROIC) | - | - | - | -122.70% | -173.03% | 5.30% | |
| Return on Capital Employed (ROCE) | -79.80% | -66.10% | -9.30% | -10.40% | -25.50% | 0.40% | |
| Earnings Yield | -35.79% | -30.93% | -3.58% | -22.02% | -15.02% | -23.41% | |
| FCF Yield | -31.55% | -4.56% | -15.58% | -7.46% | -16.89% | -19.27% | |
| Buyback Yield / Dilution | -4.15% | -0.74% | -1.02% | -0.12% | -0.77% | -17.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.